275 related articles for article (PubMed ID: 7565795)
21. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway.
Geppert TD; Whitehurst CE; Thompson P; Beutler B
Mol Med; 1994 Nov; 1(1):93-103. PubMed ID: 8790605
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
Khosravi-Far R; White MA; Westwick JK; Solski PA; Chrzanowska-Wodnicka M; Van Aelst L; Wigler MH; Der CJ
Mol Cell Biol; 1996 Jul; 16(7):3923-33. PubMed ID: 8668210
[TBL] [Abstract][Full Text] [Related]
23. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.
Aziz N; Cherwinski H; McMahon M
Mol Cell Biol; 1999 Feb; 19(2):1101-15. PubMed ID: 9891045
[TBL] [Abstract][Full Text] [Related]
24. Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein.
Ohtsuka T; Shimizu K; Yamamori B; Kuroda S; Takai Y
J Biol Chem; 1996 Jan; 271(3):1258-61. PubMed ID: 8576107
[TBL] [Abstract][Full Text] [Related]
25. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic.
Tombes RM; Auer KL; Mikkelsen R; Valerie K; Wymann MP; Marshall CJ; McMahon M; Dent P
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1451-60. PubMed ID: 9494119
[TBL] [Abstract][Full Text] [Related]
26. Biochemical analysis of MEK activation in NIH3T3 fibroblasts. Identification of B-Raf and other activators.
Reuter CW; Catling AD; Jelinek T; Weber MJ
J Biol Chem; 1995 Mar; 270(13):7644-55. PubMed ID: 7706312
[TBL] [Abstract][Full Text] [Related]
27. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells.
McCubrey JA; Steelman LS; Hoyle PE; Blalock WL; Weinstein-Oppenheimer C; Franklin RA; Cherwinski H; Bosch E; McMahon M
Leukemia; 1998 Dec; 12(12):1903-29. PubMed ID: 9844921
[TBL] [Abstract][Full Text] [Related]
28. Differential effects on cAMP on the MAP kinase cascade: evidence for a cAMP-insensitive step that can bypass Raf-1.
Faure M; Bourne HR
Mol Biol Cell; 1995 Aug; 6(8):1025-35. PubMed ID: 7579705
[TBL] [Abstract][Full Text] [Related]
29. Interferons block protein kinase C-dependent but not-independent activation of Raf-1 and mitogen-activated protein kinases and mitogenesis in NIH 3T3 cells.
Xu J; Rockow S; Kim S; Xiong W; Li W
Mol Cell Biol; 1994 Dec; 14(12):8018-27. PubMed ID: 7526152
[TBL] [Abstract][Full Text] [Related]
30. Inducible expression of a mutant form of MEK1 in Swiss 3T3 cells.
Syu LJ; Guan KL; Saltiel AR
J Cell Biochem; 1997 Dec; 67(3):367-77. PubMed ID: 9361191
[TBL] [Abstract][Full Text] [Related]
31. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos.
Okazaki K; Sagata N
Oncogene; 1995 Mar; 10(6):1149-57. PubMed ID: 7700641
[TBL] [Abstract][Full Text] [Related]
32. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
Salmeron A; Ahmad TB; Carlile GW; Pappin D; Narsimhan RP; Ley SC
EMBO J; 1996 Feb; 15(4):817-26. PubMed ID: 8631303
[TBL] [Abstract][Full Text] [Related]
33. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway.
Pumiglia KM; Decker SJ
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):448-52. PubMed ID: 9012803
[TBL] [Abstract][Full Text] [Related]
35. A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras.
Schaap D; van der Wal J; Howe LR; Marshall CJ; van Blitterswijk WJ
J Biol Chem; 1993 Sep; 268(27):20232-6. PubMed ID: 8397201
[TBL] [Abstract][Full Text] [Related]
36. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.
Schönwasser DC; Marais RM; Marshall CJ; Parker PJ
Mol Cell Biol; 1998 Feb; 18(2):790-8. PubMed ID: 9447975
[TBL] [Abstract][Full Text] [Related]
37. A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function.
Catling AD; Schaeffer HJ; Reuter CW; Reddy GR; Weber MJ
Mol Cell Biol; 1995 Oct; 15(10):5214-25. PubMed ID: 7565670
[TBL] [Abstract][Full Text] [Related]
38. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
Seternes OM; Johansen B; Moens U
Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells.
Weissinger EM; Eissner G; Grammer C; Fackler S; Haefner B; Yoon LS; Lu KS; Bazarov A; Sedivy JM; Mischak H; Kolch W
Mol Cell Biol; 1997 Jun; 17(6):3229-41. PubMed ID: 9154822
[TBL] [Abstract][Full Text] [Related]
40. Growth factor induced MEK activation is primarily mediated by an activator different from c-raf.
Zheng CF; Ohmichi M; Saltiel AR; Guan KL
Biochemistry; 1994 May; 33(18):5595-9. PubMed ID: 8180183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
